Skip to main content
SpringerLink
Log in

The cellular and molecular basis of natural antitumor immunity in renal cell carcinoma patients

  • Main Topic
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Motzer RJ, Bander NH, Nanus DM (1996) Renal-cell carcinoma. N Engl J Med 335:865–875

    Article  CAS  PubMed  Google Scholar 

  2. Schendel DJ, Oberneder R, Falk CS, Jantzer P, Kressenstein S, Maget B, Hofstetter A, Riethmüller G, Nößner, E (1997) Cellular and molecular analyses of MHC-restricted and non-MHC-restricted effector cells recognizing renal carcinomas: problems and perspectives for immunotherapy. J Mol Med 75:400–413

    Article  CAS  PubMed  Google Scholar 

  3. Schendel DJ, Gansbacher B, Oberneder R, Kriegmair M, Hofstetter A, Riethmüller G, Segurado OG (1993) Tumor-specific lysis of renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. J Immunol 151:4209–4220

    CAS  PubMed  Google Scholar 

  4. Jantzer P, Schendel DJ (1998) Human renal cell carcinoma antigen-specific cytotoxic T lymphocytes: antigen-driven selection and long-term persistence in vivo. Cancer Res 58:3078–3086

    CAS  PubMed  Google Scholar 

  5. Nößner E, Schendel DJ (1999) Autologous and allogeneic tumor cell vaccines. In Blankenstein T (ed) Gene therapy, principles and applications. Birkhäuser, Basel, pp 299–312

  6. Schendel DJ, Gansbacher B (1993) Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. II. Modulation of recognition through retroviral transduction of tumor cells with IL-2 cDNA and exogenous interferon-alpha treatment. Cancer Res 53:4020–4025

    CAS  PubMed  Google Scholar 

  7. Schendel DJ, Frankenberger B, Jantzer P, Cayeux S, Nößner E, Willimsky G, Maget B, Pohla H, Blankenstein T (2000) Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse. Gene Ther 7:2007–2014

    Article  CAS  PubMed  Google Scholar 

  8. Pohla H, Frankenberger B, Stadlbauer B, Oberneder R, Hofstetter A, Willimsky G, Pezzutto A, Dörken B, Blankenstein T, Schendel DJ (2000) Allogeneic vaccination for renal cell carcinoma: development and monitoring. Bone Marrow Transplant 25:83–87

    Article  Google Scholar 

  9. Becker C, Pohla H, Frankenberger B, Assenmacher M, Schendel DJ, Blankenstein T (2001) Adoptive tumor therapy with T lymphocytes enriched through an IFNγ capture assay. Nature Med 7:1159–1162

    Article  CAS  PubMed  Google Scholar 

  10. Schleypen JS, von Geldern M, Weiß EH, Kotzias N, Rohrmann K, Schendel DJ, Falk CS, Pohla H (2003) Renal cell carcinoma infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I-allotype. Int J Cancer 106:905–912

    Article  CAS  PubMed  Google Scholar 

  11. Schendel DJ, Falk CS, Nößner E, Maget B, Kressenstein S, Urlinger S, Tampe’ R, Gansbacher B (2000) Gene transfer of human interferon gamma complementary DNA into renal cell carcinoma lines enhances MHC-restricted cytotoxic T lymphocyte recognition but suppresses non-MHC-restricted effector cell activity. Gene Ther 7:950–959

    Article  CAS  PubMed  Google Scholar 

  12. Falk CS, Noessner E, Weiss EH, Schendel DJ (2002) Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer (LAK)-derived T cells. Cancer Res 62:480–487

    CAS  PubMed  Google Scholar 

  13. Falk CS, Schendel DJ (2002) Allogeneic MHC class I ligands and their role in positive and negative regulation of human cytotoxic effector cells. Human Immunol 63:8–19

    Article  CAS  Google Scholar 

  14. Noessner E, Falk CS, Schendel DJ (2003) Interferon alpha and gamma differentially alter the susceptibility of tumor cells to lysis by MHC-restricted and non-MHC-restricted cytotoxic effector cells. In Hiddemann W, Büchner T, Ritter J, Unterhalt M, Haferlach T (eds) Acute leukemias IX: basic research, experimental approaches and novel therapies. Springer, Berlin Heidelberg New York, pp 497–503

Download references

Conflict of interest:

No information supplied

Author information

Authors and Affiliations

  1. Institute of Molecular Immunology, GSF National Research Center for Environment and Health, Munich, Germany

    Dolores J. Schendel, C. S. Falk, B. Frankenberger, E. Noessner, J. Schleypen & H. Pohla

  2. Clinical Cooperation Group “Urological Tumors”, Laboratory of Tumor Immunology, Department of Urology, Ludwig-Maximilians University, Munich, Germany

    J. Schleypen & H. Pohla

  3. Institute of Molecular Immunology, Marchioninistrasse 25, 81377, Munich, Germany

    Dolores J. Schendel

Authors
  1. Dolores J. Schendel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. S. Falk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Frankenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Noessner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Schleypen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Pohla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dolores J. Schendel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schendel, D.J., Falk, C.S., Frankenberger, B. et al. The cellular and molecular basis of natural antitumor immunity in renal cell carcinoma patients. Urologe 43 (Suppl 3), 133–135 (2004). https://doi.org/10.1007/s00120-004-0601-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-004-0601-y

Keywords

Search

Navigation